Improving HIV prevention through better delivery of PrEP in Kenya
Delivery of PrEP to Key Populations in Kenya: Applying Coincidence Analysis to Determine Effective Implementation Strategies
This study is looking at how to make it easier for people in Kenya who are at high risk of HIV to start and keep using a medication called PrEP to help prevent the virus, so they can stay healthy and safe.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of South Florida NIH-funded |
| Lab location | 1 site (Tampa, United States) |
| Project ID | NIH-10700586 on NIH RePORTER |
What this research studies
This research investigates how to enhance the delivery of pre-exposure prophylaxis (PrEP) for HIV prevention among key populations in Kenya. It aims to identify effective implementation strategies and contextual factors that influence the initiation and persistence of PrEP use. By analyzing existing programs and collecting data from healthcare organizations, the study seeks to understand what works best in encouraging individuals at high risk of HIV to start and continue using PrEP. The findings will help improve HIV prevention efforts in the region.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals in Kenya who are at high risk of acquiring HIV and are eligible for PrEP.
Not a fit: Patients who are not at risk for HIV or those who do not reside in Kenya may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to increased access to and sustained use of PrEP, significantly reducing the risk of HIV transmission among vulnerable populations.
How similar studies have performed: Previous research has shown success in improving PrEP uptake through targeted implementation strategies, making this approach both relevant and promising.
Where this research is happening
Tampa, United States
- University of South Florida — Tampa, United States (Active)
Researchers
- Principal investigator: Turner, Deanne — University of South Florida
- Study coordinator: Turner, Deanne
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.